Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial atrial fibrillation in which the cause of the disease is a mutation in the KCNE2 gene.
Features include always present findings: Atrial fibrillation and Premature atrial contractions; and very common findings: Palpitations. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 4 | Permanent atrial fibrillation, Atrial fibrillation, Paroxysmal atrial fibrillation |
KCNE2 encodes potassium voltage-gated channel subfamily E regulatory subunit 2 (123 aa). Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. Highest expression in Stomach (306.8 TPM) and Testis (5.9 TPM).
Atrial fibrillation, familial, 4 is associated with mutations in the KCNE2 gene on chromosome 21.
KCNE2 is classified as a druggable target (Cell Surface and Ion Channel categories) with score 4.0.
Genetic testing for KCNE2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for atrial fibrillation, familial, 4 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 1 very common feature, 1 common feature.
No clinical trials have been registered for atrial fibrillation, familial, 4.
288 publications have been identified in PubMed for atrial fibrillation, familial, 4. Kisho has analyzed 153 by research type. Research spans Epidemiology / Natural History (30%), Clinical Trial Publication (28%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 46 | 30% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:14 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Clinical study results |
43 |
28% |
Laboratory research | 28 | 18% |
Research summaries | 19 | 12% |
Testing and diagnosis research | 7 | 5% |
Other research | 4 | 3% |
Patient case studies | 4 | 3% |
New treatment approaches | 2 | 1% |
Segar MW (2026). [PMID: 40188996](https://pubmed.ncbi.nlm.nih.gov/40188996/). *Heart rhythm*. [Epidemiology / Natural History]
Mondragon RR (2026). [PMID: 41183722](https://pubmed.ncbi.nlm.nih.gov/41183722/). *Free radical biology & medicine*. [Review / Meta-Analysis]
Chamoieva A (2026). [PMID: 41745353](https://pubmed.ncbi.nlm.nih.gov/41745353/). *J Pers Med*. [Basic Science / Preclinical]
Bálint T (2026). [PMID: 40412601](https://pubmed.ncbi.nlm.nih.gov/40412601/). *Heart rhythm*. [Basic Science / Preclinical]
Nakashima K (2026). [PMID: 40996829](https://pubmed.ncbi.nlm.nih.gov/40996829/). *Eur Heart J*. [Basic Science / Preclinical]
Li JZ (2026). [PMID: 40221274](https://pubmed.ncbi.nlm.nih.gov/40221274/). *Cardiovascular revascularization medicine : including molecular interventions*. [Epidemiology / Natural History]
Dong Z (2026). [PMID: 40052861](https://pubmed.ncbi.nlm.nih.gov/40052861/). *The Journal of physiology*. [Epidemiology / Natural History]
Rankinen J (2026). [PMID: 40664496](https://pubmed.ncbi.nlm.nih.gov/40664496/). *Heart (British Cardiac Society)*. [Clinical Trial Publication]
Shamaki GR (2025). [PMID: 39631636](https://pubmed.ncbi.nlm.nih.gov/39631636/). *Current problems in cardiology*. [Epidemiology / Natural History]
Bao C (2025). [PMID: 40970482](https://pubmed.ncbi.nlm.nih.gov/40970482/). *Journal of the American Heart Association*. [Basic Science / Preclinical]